A phase II study alternating alpha-2a-interferon and gamma-interferon therapy in patients with chronic myelogenous leukemia
Open Access
- 15 November 1991
- Vol. 68 (10) , 2125-2130
- https://doi.org/10.1002/1097-0142(19911115)68:10<2125::aid-cncr2820681006>3.0.co;2-q
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Immunomodulators in Clinical MedicineAnnals of Internal Medicine, 1987
- ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKAEMIAThe Lancet, 1984
- Alpha Interferon for Induction of Remission in Hairy-Cell LeukemiaNew England Journal of Medicine, 1984
- Allogeneic bone marrow transplantation as treatment for accelerating chronic myelogenous leukemiaBlood, 1984
- Chronic Myelogenous Leukemia — New ConceptsNew England Journal of Medicine, 1981
- Interferon induced in human leukocytes by mitogens: production, partial purification and characterizationEuropean Journal of Immunology, 1980
- Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant LymphomaAnnals of Internal Medicine, 1980
- Restoration of nonclonal hematopoiesis in chronic myelogenous leukemia (CML) following a chemotherapy-induced loss of the Ph1 chromosomeBlood, 1980
- Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferonCellular Immunology, 1980
- Results of treatment of Ph'+ chronic myelogenous leukemia with an intensive treatment regimen (L-5 protocol)Blood, 1979